Full Text (PDF)
Case Report

Prevention of Surge in Cytokines: Sjogren’s Syndrome for Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy

Kirthiha Govindaraj null, Gnanasekaran Srinivasan1 null, Kirthiha Govindaraj2 null, Ameena Mohammed3 null

Author Information

Licence:

Attribution-Non-commercial 4.0 International (CC BY-NC 4.0)

This license enables reusers to distribute, remix, adapt, and build upon the material in any medium or format for noncommercial purposes only, and only so long as attribution is given to the creator.


Indian Journal of Cancer Education and Research 10(2):p 97-100, july-december 2022. | DOI: https://doi.org/10.21088/ijcer.2321.9815.10222.6

How Cite This Article:

How to cite this article: Gnanasekaran Srinivasan, Kirthiha Govindaraj, Ameena Mohammed/Prevention of Surge in Cytokines: Sjogren’s Syndrome for Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy/Indian J Canc Educ Res 2022;10(2):97-100.


Timeline

Received : November 25, 2022         Accepted : December 11, 2022          Published : December 30, 2022

Abstract

Pseudomyxoma peritoni is treatable with newer surgical modalities like cytoreductive surgery and hyperthermic 
intraperitoneal chemotherapy (HIPEC), and the anesthetic management can be challenging. In our case, the 
perioperative management was further complicated by the presence of Sjogren’s syndrome which has its own 
anesthetic implications. This may be the first reported case of anesthetic management of HIPEC in a patient having 
Sjogren’s syndrome along with its perioperative considerations include fluid management, stable hemodynamics, 
thermoregulation, electrolyte balance, intraoperative massive fluid shifts, ventilatory management, avoidance of 
renal toxicity and suppression of cytokines release plays a major role in the management in this patient.


References

  • 1.   Mishra R, Sharma K, Barpande J, Kumari N, Mehta H. Anaesthetic Management of Cytoreductive Surgery with Hyperthermic Intraperitoneal Chemotherapy (CRS/HIPEC): A True Challenge To an Anaesthetist. Journal of Current Medical Research and Opinion. 2020;03(07):503-507.
  • 2.   Smeenk RM, Velthuysen MLFV, Verwaal VJ, Zoetmulder FAN. Appendiceal neoplasms and pseudomyxoma peritonei: A population based study.
  • 3.   Patel R, Shahane A. The epidemiology of Sjögren’s syndrome. Clinical Epidemiology. 2014:6 247–255.
  • 4.   Balakrishnan KP, Survesan S. Anaesthetic management and perioperative outcomes of cytoreductive surgery with hyperthermic intraperitoneal chemotherapy: A retrospective.
  • 5.   analysis. Indian J Anaesth 2018;62:188-96.
  • 6.   Solank SL, Mukherjee S, Agarwal V, Thota RS, Balakrishnan K, Shah SB, Desai N, Garg R, Ambulkar RP, Bhorkar NM, Patro V, Sinukumar S, Venketeswaran MV, Joshi MP, Chikkalingegowda RH, Gottumukkala V, Owusu-Agyemang P, Saklani AP, Mehta SS, Seshadri RA, Bell JC, Bhatnagar S, Divatia JV. Society of Onco-Anaesthesia and Perioperative Care consensus guidelines for perioperative management of patients for cytoreductive surgery and hyperthermic intraperitoneal chemotherapy (CRS-HIPEC). Indian J Anaesth 2019;63:972-87.
  • 7.   Renuka R. Anesthetic Management of a Rare Case of Primary Sjogren’s Syndrome for a Gynecological Surgery. IndianJournalofAnesthes iaandAnalgesia .2020;7(1):191-194.
  • 8.   Babazade R, Sun Z, Hesler BD, Sharma A, Makarova N, Dalton JE, and Turan A. The Association Between Sjögren Syndrome and Adverse Postoperative Outcomes: A Historical Cohort Study Using Administrative Health Data. Anesthesia and Analgesia. 2015; 121(5):1222-1230.
  • 9.   Roescher N, Tak PP, Illei GG. Cytokines I Sjogren’s syndrome: potential therapeutic targets. Ann Rheum Dis. 2010;69(6).
  • 10.   Fan CN, Yang SJ, Shih PY, Wang MJ, Fan SJ, Tsai JC, Sun WZ, Liu CM, Yeh YC. Comapring effects of intraoperative fluid and vasopressor infusion on intestinal microcirculation.Scientific reports.2020;10:19856.

Data Sharing Statement

There are no additional data available. All raw data and code are available upon request.

Funding

This research received no funding.

Author Contributions

All authors contributed significantly to the work and approve its publication.

Ethics Declaration

This article does not involve any human or animal subjects, and therefore does not require ethics approval.

Acknowledgements

We would like to express our gratitude to the patients, their families, and all those who have contributed to this study.

Conflicts of Interest

No conflicts of interest in this work.


About this article


Cite this article

How to cite this article: Gnanasekaran Srinivasan, Kirthiha Govindaraj, Ameena Mohammed/Prevention of Surge in Cytokines: Sjogren’s Syndrome for Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy/Indian J Canc Educ Res 2022;10(2):97-100.


Licence:

Attribution-Non-commercial 4.0 International (CC BY-NC 4.0)

This license enables reusers to distribute, remix, adapt, and build upon the material in any medium or format for noncommercial purposes only, and only so long as attribution is given to the creator.


Received Accepted Published
November 25, 2022 December 11, 2022 December 30, 2022

DOI: https://doi.org/10.21088/ijcer.2321.9815.10222.6

Keywords

Keywords: Sjogren’s Syndrome; Hyperthermic; Chemotherapy; Stable hemodynamics; cytokines release plays.Sjogren’s SyndromeHyperthermicChemotherapyStable hemodynamics;cytokines release plays

Article Level Metrics

Last Updated

Friday 31 July 2026, 16:50:24 (IST)


1319

Accesses

11
266
00

Citations


NA
NA
NA

Download citation


Article Keywords


Keyword Highlighting

Highlight selected keywords in the article text.


Timeline


Received November 25, 2022
Accepted December 11, 2022
Published December 30, 2022

licence


Attribution-Non-commercial 4.0 International (CC BY-NC 4.0)

This license enables reusers to distribute, remix, adapt, and build upon the material in any medium or format for noncommercial purposes only, and only so long as attribution is given to the creator.


Access this article



Share